Skip to main content
. 2021 Apr 9;22(8):3897. doi: 10.3390/ijms22083897
Aptamer Type Target Stage References
SM-20 RNA Plasminogen activator inhibitor-1 Pre-clinical [109,110,111]
WT-15 RNA Plasminogen activator inhibitor-1 Pre-clinical [109,110,111]
Paionap-5 RNA Plasminogen activator inhibitor-1 Pre-clinical [112]
Paionap-40 RNA Plasminogen activator inhibitor-1 Pre-clinical [112]
R10-2 RNA Plasminogen activator inhibitor-1 Pre-clinical [113]
R10-4 RNA Plasminogen activator inhibitor-1 Pre-clinical [113]
Upanap-12 RNA Urokinase-type plasminogen activator Pre-clinical [114]
Upanap-12.49 RNA Urokinase-type plasminogen activator Pre-clinical [114]
Upanap-126 RNA Urokinase-type plasminogen activator Pre-clinical [115]
unnamed RNA Urokinase-type plasminogen activator Pre-clinical [116]
K18v2 RNA Tissue-type plasminogen activator Pre-clinical [117]
K32v2 RNA Tissue-type plasminogen activator Pre-clinical [117]
3218 RNA Tissue-type plasminogen activator Pre-clinical [118]